Screener
Viridian Therapeutics, Inc. VRDN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s current ratio?
- Viridian Therapeutics, Inc. (VRDN) reported current ratio of 16.9× in Q2 2026.
- How has Viridian Therapeutics, Inc.'s current ratio changed year-over-year?
- Viridian Therapeutics, Inc.'s current ratio increased by 54.0% year-over-year, from 11× to 16.9×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s current ratio has grown at a 0.8% compound annual growth rate (CAGR), from 12.1× to 12.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Viridian Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude